It provides a comprehensive and up-to-date overview of the broad therapeutic landscape of GLP-1 RAs by consolidating the findings from multiple large-scale, randomized controlled trials (n = 15 publications)
[11] [12] FDA-approved GLP-1 agonists include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon), among others
Reitano told CNBC in March that after the FDA approved Wegovy in 2021, patient inquiries about the medication began flooding in by the "tens of thousands." As a result, the company launched a GLP-1 program called the Ro Body Program early last year
Weight loss injections can feel controversial, and a patch may seem easier to keep privateno navigating injections while traveling or staying with family, for example
Pricing is visible before sign-up, but medical authority is deliberately deferred until after intake and clinician review
And it's definitely not going to replace the boring, unsexy work of developing a healthy relationship with food
